Search Results - "LIECHTI, M. E"

Refine Results
  1. 1

    Pharmacological characterization of designer cathinones in vitro by Simmler, LD, Buser, TA, Donzelli, M, Schramm, Y, Dieu, L‐H, Huwyler, J, Chaboz, S, Hoener, MC, Liechti, ME

    Published in British journal of pharmacology (01-01-2013)
    “…Background and Purpose Designer β‐keto amphetamines (e.g. cathinones, ‘bath salts’ and ‘research chemicals’) have become popular recreational drugs, but their…”
    Get full text
    Journal Article
  2. 2

    Monoamine transporter and receptor interaction profiles of a new series of designer cathinones by Simmler, L.D., Rickli, A., Hoener, M.C., Liechti, M.E.

    Published in Neuropharmacology (01-04-2014)
    “…Psychoactive β-keto amphetamines (cathinones) are sold as “bath salts” or “legal highs” and recreationally abused. We characterized the pharmacology of a new…”
    Get full text
    Journal Article
  3. 3

    Acute LSD effects on response inhibition neural networks by Schmidt, A, Müller, F, Lenz, C, Dolder, P C, Schmid, Y, Zanchi, D, Lang, U E, Liechti, M E, Borgwardt, S

    Published in Psychological medicine (01-07-2018)
    “…Recent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual hallucinations…”
    Get more information
    Journal Article
  4. 4

    The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA ("Ecstasy") in Humans by Hysek, CM, Simmler, LD, Ineichen, M, Grouzmann, E, Hoener, MC, Brenneisen, R, Huwyler, J, Liechti, ME

    Published in Clinical pharmacology and therapeutics (01-08-2011)
    “…This study assessed the pharmacodynamic and pharmacokinetic effects of the interaction between the selective norepinephrine (NE) transporter inhibitor…”
    Get full text
    Journal Article
  5. 5

    Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans by Hysek, CM, Schmid, Y, Rickli, A, Simmler, LD, Donzelli, M, Grouzmann, E, Liechti, ME

    Published in British journal of pharmacology (01-08-2012)
    “…BACKGROUND AND PURPOSE The use of ±3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) is associated with cardiovascular complications and hyperthermia…”
    Get full text
    Journal Article
  6. 6

    Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects by Strajhar, P., Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K. M., Kratschmar, D. V., Odermatt, A., Liechti, M. E.

    Published in Journal of neuroendocrinology (01-03-2016)
    “…Lysergic acid diethylamide (LSD) is a serotonin 5‐hydroxytryptamine‐2A (5‐HT2A) receptor agonist that is used recreationally worldwide. Interest in LSD…”
    Get full text
    Journal Article
  7. 7

    Gender differences in the subjective effects of MDMA by LIECHTI, Matthias E, GAMMA, Alex, VOLLENWEIDER, Franz X

    Published in Psychopharmacologia (01-03-2001)
    “…3.4-Methylenedioxymethamphetamine (MDMA) mainly releases serotonin (5-HT) and is contained in the recreational drug Ecstasy. 5-HT is known to play an important…”
    Get full text
    Journal Article
  8. 8

    Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects by Mueller, F, Lenz, C, Dolder, P C, Harder, S, Schmid, Y, Lang, U E, Liechti, M E, Borgwardt, S

    Published in Translational psychiatry (04-04-2017)
    “…Lysergic acid diethylamide (LSD) induces profound changes in various mental domains, including perception, self-awareness and emotions. We used functional…”
    Get full text
    Journal Article
  9. 9

    Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram by Liechti, Matthias E., Baumann, Christine, Gamma, Alex, Vollenweider, Franz X.

    Published in Neuropsychopharmacology (New York, N.Y.) (01-05-2000)
    “…3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) is a recreational drug that has been shown to release serotonin (5-HT) and dopamine (DA) in animals. The…”
    Get full text
    Journal Article
  10. 10

    Neuroimaging in moderate MDMA use: A systematic review by Mueller, F, Lenz, C, Steiner, M, Dolder, P C, Walter, M, Lang, U E, Liechti, M E, Borgwardt, S

    Published in Neuroscience and biobehavioral reviews (01-03-2016)
    “…MDMA ("ecstasy") is widely used as a recreational drug, although there has been some debate about its neurotoxic effects in humans. However, most studies have…”
    Get full text
    Journal Article
  11. 11

    The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers by Liechti, Matthias E., Vollenweider, Franz X.

    Published in Journal of psychopharmacology (Oxford) (01-05-2000)
    “…MDMA (3, 4-methylenedioxymethamphetamine) or ‘Ecstasy’ is a widely used recreational drug that produces a state of heightened mood but also cardiovascular and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Plasmodium falciparum cerebral malaria complicated by disseminated intravascular coagulation and symmetrical peripheral gangrene: Case report and review by LIECHTI, M. E, ZUMSTEG, V, HATZ, C. F. R, HERREN, T

    “…The case of a 56-year-old female tourist who survived cerebral Plasmodium falciparum malaria with disseminated intravascular coagulation and symmetrical…”
    Get full text
    Journal Article
  14. 14

    Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy) by Hysek, C M, Vollenweider, F X, Liechti, M E

    Published in Emergency medicine journal : EMJ (01-08-2010)
    “…MDMA (3,4-methylenedioxymethamphetamine, 'Ecstasy') produces tachycardia and hypertension and is rarely associated with cardiovascular and cerebrovascular…”
    Get more information
    Journal Article
  15. 15

    Acute psychological and physiological effects of MDMA (“Ecstasy”) after haloperidol pretreatment in healthy humans by Liechti, Matthias E., Vollenweider, Franz X.

    Published in European neuropsychopharmacology (01-07-2000)
    “…3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) releases serotonin and dopamine. The role for dopamine in mediating the effects of MDMA has not yet been…”
    Get full text
    Journal Article
  16. 16

    Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin by Liechti, Matthias E, Geyer, Mark A, Hell, Daniel, Vollenweider, Franz X

    Published in Neuropsychopharmacology (New York, N.Y.) (01-03-2001)
    “…Prepulse inhibition (PPI) of the acoustic startle response is an operational measure of sensorimotor gating that can be assessed in animals and in humans…”
    Get full text
    Journal Article
  17. 17

    In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1 by Simmler, Linda D, Buchy, Danièle, Chaboz, Sylvie, Hoener, Marius C, Liechti, Matthias E

    “…Trace amine-associated receptor 1 (TAAR1) has been implicated in the behavioral effects of amphetamine-type stimulant drugs in rodents. TAAR1 has also been…”
    Get more information
    Journal Article
  18. 18

    Presentations to the Emergency Department Following Cannabis use—a Multi-Centre Case Series from Ten European Countries by Dines, Alison M., Wood, David M., Galicia, Miguel, Yates, Christopher M., Heyerdahl, Fridtjof, Hovda, Knut Erik, Giraudon, Isabelle, Sedefov, Roumen, Dargan, Paul I.

    Published in Journal of medical toxicology (01-12-2015)
    “…Cannabis is the most commonly used illicit drug in Europe, and is generally regarded as having low acute toxicity. We present the findings of the first…”
    Get full text
    Journal Article
  19. 19

    Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome by Rickli, Anna, Liakoni, Evangelia, Hoener, Marius C, Liechti, Matthias E

    Published in British journal of pharmacology (01-02-2018)
    “…Background and Purpose Opioids may inhibit the 5‐HT transporter (SERT) and the noradrenaline transporter (NET). NET inhibition may contribute to analgesia, and…”
    Get full text
    Journal Article
  20. 20

    Methylphenidate misuse by Bruggisser, M, Bodmer, M, Liechti, M E

    Published in Praxis (Bern. 1994) (29-02-2012)
    “…Methylphenidate (MPH) is mainly used for treatment of the attention-deficit hyperactivity syndrome (ADHS). Non-medical use of methylphenidate as recreational…”
    Get more information
    Journal Article